PMID: 6172006Jul 1, 1981Paper

Bromocriptine treatment of depressive disorders. Clinical and biochemical effects

Acta Psychiatrica Scandinavica
C NordinL Bertilsson

Abstract

Fifteen depressed patients were treated with increasing doses of bromocriptine in an open study. Twelve were treated for 5 weeks (final dose 20-60 mg daily) and nine of these recovered almost completely. As expected from a dopamine agonist, bromocriptine decreased the level of homovanillic acid (HVA) in cerebrospinal fluid (CSF) by 15% (P less than 0.05) and 23% (P less than 0.01) after 2 and 5 weeks of treatment, respectively. After 2 but not after 5 weeks of treatment there was also a small but significant decrease (13%; P less than 0.001) of the noradrenaline metabolite HMPG in CSF. Although there was no mean effect on 5-HIAA in CSF, there was a significant relationship between the HVA and 5-HIAA levels (as % of pretreatment level) both after 2 and 5 weeks of treatment (r = 0.96 and r = 0.62, respectively). This may indicate that the drug has an effect on the serotonin system secondary to the dopamine receptor stimulation. The amelioration of depression was not related to HVA, but did correlate to HMPG in CSF (r = 0.65; P less than 0.05) both metabolites measured before treatment. These results indicate that bromocriptine may have antidepressant effects possibly mediated through the noradrenergic system rather than the dopam...Continue Reading

References

Sep 1, 1979·Journal of Affective Disorders·L ColonnaJ P Lepine
Jan 1, 1978·Acta Psychiatrica Scandinavica. Supplementum·M AsbergG Sedvall
Oct 18, 1979·The New England Journal of Medicine·D Parkes
Nov 1, 1979·Clinical Pharmacology and Therapeutics·L TräskmanG Tybring
Feb 1, 1979·Clinical Pharmacology and Therapeutics·M G ZieglerO Steinsland
Sep 1, 1974·Annals of Internal Medicine·L E Hollister
Jan 1, 1971·The American Journal of Psychiatry·W E BunneyF K Goodwin
Nov 1, 1965·The American Journal of Psychiatry·J J Schildkraut
Nov 1, 1980·European Journal of Clinical Pharmacology·L BertilssonB Siwers

❮ Previous
Next ❯

Citations

Jan 1, 1993·Psychopharmacology·J K HsiaoD Pickar
Jan 15, 1992·Biological Psychiatry·P L ReddyB S Rao
Feb 15, 1994·Biological Psychiatry·P Sachdev, A M Aniss
Jan 1, 1982·Pharmacology, Biochemistry, and Behavior·H Y Meltzer
May 1, 1987·Psychiatry Research·C A PeabodyP A Berger
Nov 28, 1997·Brain Research·C BowdenR W Horton
Apr 11, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·T WadaK Otani
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Paola RoccFilippo Bogetto
Jan 27, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·C BowdenR W Horton
Jan 1, 1999·International Journal of Psychiatry in Clinical Practice·T HiguchiM Sato
Jan 1, 1982·Current Medical Research and Opinion·N Bouras, P K Bridges
Aug 1, 1990·American Journal of Medical Genetics·D E Comings
Jan 1, 1989·Psychosomatics·N J Berwish, J D Amsterdam
Apr 30, 2005·Biological Psychiatry·Sandra López LeónCornelia M van Duijn
Mar 1, 1985·Acta Psychiatrica Scandinavica·A Aberg-WistedtH Wachtmeister
Nov 1, 1985·British Journal of Clinical Pharmacology·M Hovi-VianderM Scheinin
Aug 1, 1983·Acta Psychiatrica Scandinavica·V Borg
Jan 18, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·George I Papakostas
Jan 1, 1991·Neuroscience and Biobehavioral Reviews·R M Zacharko, H Anisman
Dec 7, 1985·British Medical Journal·I N Ferrier
Jul 1, 1989·DICP : the Annals of Pharmacotherapy·B G Wells, P A Marken
Apr 1, 1987·Medicinal Research Reviews·H RoehrichM S Gold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progress in Neuro-psychopharmacology & Biological Psychiatry
L ScarzellaB Bergamasco
Current Medical Research and Opinion
N Bouras, P K Bridges
European Journal of Clinical Pharmacology
L BertilssonB Siwers
© 2021 Meta ULC. All rights reserved